alhkim Profile Banner
Alfred Kim (moving to Bluesky as alhkim) Profile
Alfred Kim (moving to Bluesky as alhkim)

@alhkim

Followers
5K
Following
12K
Media
288
Statuses
7K

Founder/Director @WUSTL_Lupus @WUSTLMed | Assoc Program Director @WUSTL_Rheum | Chief Medical Officer @KyphaInc | Complement, Lupus, & @COVaRiPAD | #HCQbrigade

Saint Louis, MO, USA
Joined July 2008
Don't wanna be here? Send us removal request.
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
8 months
I’m finally transitioning off of Twitter (RIP) or X (whatever) and would like to get my followers on @bluesky:. Come find me there!.
0
0
7
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
2 months
Original post:.
@EuropeCognizant
Europe Cognizant
2 months
0
0
1
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
8 months
RT @rheum_cat: Greeted by curse words from @alhkim #ACR24
Tweet media one
0
2
0
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
8 months
RT @LCalabreseDO: The real implications of this impressive work is to why we make these autoAbs? This supports a physiological role @casano….
Tweet card summary image
science.org
Nasal IgA1 autoantibodies against IFN-α are associated with better COVID-19 prognosis, including fewer symptoms and robust anti–SARS-CoV-2 immunity.
0
3
0
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
9 months
RT @LCalabreseDO: These data suggest that ANAmay/could be physiologic and part our autoimmune network- it also may inform why ANA but not L….
0
1
0
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
10 months
@MicrobiomDigest
Elisabeth Bik
10 months
Didier RAOULT banned from practicing medicine for 2 years. Thank you, @Sonic_urticant for your hard work on writing this complaint.
2
1
13
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
10 months
RT @EastEndJoe: OUCH! This one hits hard!
Tweet media one
0
4K
0
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
10 months
RT @AliDuarteMD: 🚨 Positive Phase III results for obinutuzumab in lupus nephritis!🚨. ✅ Higher CRR at 76 weeks with obinutuzumab + standard….
Tweet card summary image
roche.com
Positive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy alone in people with lupus nephritis The REGENCY study met its primary endpoint, demonstrating...
0
36
0
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
10 months
RT @ChangUCanSpare: My presentation on post-transplant TMA. This thread is full of theory, which has been simmering in my head over the las….
0
45
0
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
10 months
RT @jeffsparks: Our latest study investigating risk factors for RA-ILD subtypes, led by Dr Gregory McDermott. We systematically identified/….
Tweet card summary image
acrjournals.onlinelibrary.wiley.com
Objective Rheumatoid arthritis–associated interstitial lung disease (RA-ILD) includes multiple subtypes with varying histopathology, prognosis, and potential treatments. Limited research has invest...
0
9
0
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
10 months
RT @MerriamWebster: Wait a minute.
0
567
0
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
11 months
RT @zalaly: I am not afraid! .But the post below is NOT ok. Someone who has 90 k followers is calling for my execution. I reported it, but….
0
600
0
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
11 months
RT @ashira_md: In the African diaspora, SLE patients experience unacceptable outcomes. We discuss biologic and social vulnerability, and th….
Tweet card summary image
frontiersin.org
Systemic lupus erythematosus (SLE) is a complex autoimmune condition that disproportionately impacts non-White ethnic and racial groups, particularly individ...
0
15
0
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
11 months
RT @GenShinozakiMD: FINALLLY. (Warning, this is a long thread.). It has been a long battle. My current R01 was about to end in November thi….
0
69
0
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
11 months
RT @KDAO2011: Pls spread the word — we need #SLE pts to help with this study! Pls retweet this @CreakyJoints @LupusResearch @LupusOrg @JYaz….
0
6
0
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
11 months
RT @theHumanBorch: Finally out: Characterizing T cell specific responses to vaccine and infection in HLA-DPB1*04-restricted patients across….
0
21
0
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
1 year
RT @jasonsknight: 🕸️👀.Kidney whole-transcriptome profiling in primary antiphospholipid syndrome reveals complement, interferons and NETs-re….
0
6
0
@alhkim
Alfred Kim (moving to Bluesky as alhkim)
1 year
RT @zalaly: 🚨 Coming Soon: We're publishing a major review on Long COVID and a comprehensive roadmap for policy and research priorities.….
0
306
0